Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 2
2001 3
2002 3
2003 3
2004 9
2005 12
2006 16
2007 23
2008 34
2009 27
2010 48
2011 57
2012 62
2013 54
2014 60
2015 68
2016 72
2017 92
2018 82
2019 92
2020 100
2021 93
2022 93
2023 73
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

1,039 results

Results by year

Filters applied: . Clear all
Page 1
Curcumin in Health and Diseases: Alzheimer's Disease and Curcumin Analogues, Derivatives, and Hybrids.
Chainoglou E, Hadjipavlou-Litina D. Chainoglou E, et al. Int J Mol Sci. 2020 Mar 13;21(6):1975. doi: 10.3390/ijms21061975. Int J Mol Sci. 2020. PMID: 32183162 Free PMC article. Review.
Worldwide, Alzheimer's disease (AD) is the most common neurodegenerative multifactorial disease influencing the elderly population. Nowadays, several medications, among them curcumin, are used in the treatment of AD. Curcumin, which is th …
Worldwide, Alzheimer's disease (AD) is the most common neurodegenerative multifactorial disease influencing the …
Protective Effects of Indian Spice Curcumin Against Amyloid-β in Alzheimer's Disease.
Reddy PH, Manczak M, Yin X, Grady MC, Mitchell A, Tonk S, Kuruva CS, Bhatti JS, Kandimalla R, Vijayan M, Kumar S, Wang R, Pradeepkiran JA, Ogunmokun G, Thamarai K, Quesada K, Boles A, Reddy AP. Reddy PH, et al. J Alzheimers Dis. 2018;61(3):843-866. doi: 10.3233/JAD-170512. J Alzheimers Dis. 2018. PMID: 29332042 Free PMC article. Review.
The purpose of our article is to assess the current understanding of Indian spice, curcumin, against amyloid-beta (Abeta)-induced toxicity in Alzheimer's disease (AD) pathogenesis. ...Further, recent groups have initiated studies on elderly individuals …
The purpose of our article is to assess the current understanding of Indian spice, curcumin, against amyloid-beta (Abeta)-induced tox …
Curcumin Scaffold as a Multifunctional Tool for Alzheimer's Disease Research.
Yang H, Zeng F, Luo Y, Zheng C, Ran C, Yang J. Yang H, et al. Molecules. 2022 Jun 17;27(12):3879. doi: 10.3390/molecules27123879. Molecules. 2022. PMID: 35745002 Free PMC article. Review.
Alzheimer's disease (AD) is one of the most common neurodegenerative disorders, which is caused by multi-factors and characterized by two histopathological hallmarks: amyloid-beta (Abeta) plaques and neurofibrillary tangles of Tau proteins. ...Curcumin …
Alzheimer's disease (AD) is one of the most common neurodegenerative disorders, which is caused by multi-factors and ch …
Curcumin-loaded PLGA-PEG nanoparticles conjugated with B6 peptide for potential use in Alzheimer's disease.
Fan S, Zheng Y, Liu X, Fang W, Chen X, Liao W, Jing X, Lei M, Tao E, Ma Q, Zhang X, Guo R, Liu J. Fan S, et al. Drug Deliv. 2018 Nov;25(1):1091-1102. doi: 10.1080/10717544.2018.1461955. Drug Deliv. 2018. PMID: 30107760 Free PMC article.
Curcumin (Cur) has been proved to have potential use in Alzheimer's disease with its anti-amyloid, anti-inflammatory, and anti-oxidant properties, etc. ...Thus, we suggested that PLGA-PEG-B6/Cur nanoparticles would be of potential and promising use for …
Curcumin (Cur) has been proved to have potential use in Alzheimer's disease with its anti-amyloid, anti-inflamma …
Pharmacological considerations for treating neuroinflammation with curcumin in Alzheimer's disease.
Zhou X, Venigalla M, Raju R, Münch G. Zhou X, et al. J Neural Transm (Vienna). 2022 Jun;129(5-6):755-771. doi: 10.1007/s00702-022-02480-x. Epub 2022 Mar 16. J Neural Transm (Vienna). 2022. PMID: 35294663 Review.
Peter Riederer, the former Head of the Neurochemistry Department of the Psychiatry and Psychotherapy Clinic at the University of Wurzburg (Germany), has been one of the pioneers of research into oxidative stress in Parkinson's and Alzheimer's disease ( …
Peter Riederer, the former Head of the Neurochemistry Department of the Psychiatry and Psychotherapy Clinic at the University of Wurzburg (G …
Dietary Supplementation with Curcumin Reduce Circulating Levels of Glycogen Synthase Kinase-3β and Islet Amyloid Polypeptide in Adults with High Risk of Type 2 Diabetes and Alzheimer's Disease.
Thota RN, Rosato JI, Dias CB, Burrows TL, Martins RN, Garg ML. Thota RN, et al. Nutrients. 2020 Apr 9;12(4):1032. doi: 10.3390/nu12041032. Nutrients. 2020. PMID: 32283762 Free PMC article. Clinical Trial.
Dietary supplementation with curcumin has been previously reported to have beneficial effects in people with insulin resistance, type 2 diabetes (T2D) and Alzheimer's disease (AD). ...Dietary supplementation with curcumin reduced circulating lev …
Dietary supplementation with curcumin has been previously reported to have beneficial effects in people with insulin resistance, type …
Highly sensitive Curcumin-conjugated nanotheranostic platform for detecting amyloid-beta plaques by magnetic resonance imaging and reversing cognitive deficits of Alzheimer's disease via NLRP3-inhibition.
Ruan Y, Xiong Y, Fang W, Yu Q, Mai Y, Cao Z, Wang K, Lei M, Xu J, Liu Y, Zhang X, Liao W, Liu J. Ruan Y, et al. J Nanobiotechnology. 2022 Jul 14;20(1):322. doi: 10.1186/s12951-022-01524-4. J Nanobiotechnology. 2022. PMID: 35836190 Free PMC article.
BACKGROUND: Alzheimer's disease (AD) is the most common neurodegenerative disorder without effective therapy and lack diagnosis strategy for preclinical AD patients. ...RESULTS: Herein, we developed a nanotheranostics platform consisting of Curcumin (C …
BACKGROUND: Alzheimer's disease (AD) is the most common neurodegenerative disorder without effective therapy and lack d …
The Mechanisms of Action of Curcumin in Alzheimer's Disease.
Tang M, Taghibiglou C. Tang M, et al. J Alzheimers Dis. 2017;58(4):1003-1016. doi: 10.3233/JAD-170188. J Alzheimers Dis. 2017. PMID: 28527218 Review.
Alzheimer's disease (AD) is a neurodegenerative disorder of the elderly. ...In conclusion, curcumin has the potential to be more efficacious than current treatments. ...
Alzheimer's disease (AD) is a neurodegenerative disorder of the elderly. ...In conclusion, curcumin has the pote …
The impact of curcumin and its modified formulations on Alzheimer's disease.
Farkhondeh T, Samarghandian S, Pourbagher-Shahri AM, Sedaghat M. Farkhondeh T, et al. J Cell Physiol. 2019 Aug;234(10):16953-16965. doi: 10.1002/jcp.28411. Epub 2019 Mar 7. J Cell Physiol. 2019. PMID: 30847942 Review.
Alzheimer's disease (AD) is a major health problem worldwide, with no effective treatment approach. ...However, there are no sufficient clinical trials to confirm curcumin use in AD patients. Low bioavailability following oral administration of curc …
Alzheimer's disease (AD) is a major health problem worldwide, with no effective treatment approach. ...However, there a …
Curcumin in Alzheimer's disease: Can we think to new strategies and perspectives for this molecule?
Serafini MM, Catanzaro M, Rosini M, Racchi M, Lanni C. Serafini MM, et al. Pharmacol Res. 2017 Oct;124:146-155. doi: 10.1016/j.phrs.2017.08.004. Epub 2017 Aug 12. Pharmacol Res. 2017. PMID: 28811228 Review.
One of the most invalidating outcomes of aging in the elderly is cognitive decline, leading to dementia and often related to neurodegenerative disorders. Among these latter, Alzheimer's disease (AD) is the major cause of dementia, affecting more than 30 milli …
One of the most invalidating outcomes of aging in the elderly is cognitive decline, leading to dementia and often related to neurodegenerati …
1,039 results

Searches related to "curcumin alzheimer's"